Publications
By Year
Now showing items 2561-2580 of 5325 records
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Tom G Richardson; Eleanor Sanderson; Tom M Palmer; Mika Ala-Korpela; Brian A Ference; George Davey Smith; Michael V Holmes
PLOS MEDICINE - 01 Mar 2020
Circulating lipoprotein lipids cause coronary heart disease (CHD). However, the precise way in which one or more lipoprotein lipid-related entities account for this relationship remains unclear. Using genetic instruments for lipoprotein lipid traits implemented through multivariable Mendelian randomisation (MR), we sought to compare their causal roles in the aetiology of CHD.We conducted a geno...
Short- and long-term outcomes of out-of-hospital cardiac arrest following ST-elevation myocardial infarction managed with percutaneous coronary intervention.
Luke P Dawson; Diem Dinh; Stephen Duffy; Angela Brennan; David Clark; Christopher M Reid; David Blusztein; Dion Stub; Nick Andrianopoulos; Melanie Freeman; Ernesto Oqueli; Andrew E Ajani;
RESUSCITATION - 01 May 2020
Out-of-hospital cardiac arrest (OHCA) is frequently associated with ST-elevation myocardial infarction (STEMI) and has a high mortality. We aimed to identify differences in characteristics and very long-term outcomes for STEMI patients with and without OHCA managed with percutaneous coronary intervention (PCI).We analysed data from 12,637 PCI patient procedures for STEMI in the multi-centre Mel...
Young-onset type 2 diabetes mellitus - implications for morbidity and mortality.
Dianna J Magliano; Julian W Sacre; Jessica L Harding; Edward W Gregg; Paul Z Zimmet; Jonathan E Shaw
NATURE REVIEWS. ENDOCRINOLOGY - 01 Jun 2020
Accumulating data suggest that type 2 diabetes mellitus (T2DM) in younger people (aged <40 years), referred to as young-onset T2DM, has a more rapid deterioration of β-cell function than is seen in later-onset T2DM. Furthermore, individuals with young-onset T2DM seem to have a higher risk of complications than those with type 1 diabetes mellitus. As the number of younger adults with T2DM increa...
Type 2 Diabetes Mellitus Is Independently Associated With Decreased Neural Baroreflex Sensitivity: The Paris Prospective Study III.
Domonkos Cseh; Rachel E Climie; Lucile Offredo; Catherine Guibout; Frédérique Thomas; Luca Zanoli; Nicolas Danchin; James E Sharman; Stéphane Laurent; Xavier Jouven; Pierre Boutouyrie; Jean-Philippe Empana
ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY - 01 May 2020
Impaired baroreflex function is an early indicator of cardiovascular autonomic imbalance. Patients with type 2 diabetes mellitus (T2D) have decreased baroreflex sensitivity (BRS), however, whether the neural BRS (nBRS) and mechanical component of the BRS is altered in those with high metabolic risk (HMR, impaired fasting glucose and metabolic syndrome) or with overt T2D, is unknown. We examined...
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.
Felix Mahfoud; Michel Azizi; Sebastian Ewen; Atul Pathak; Christian Ukena; Peter J Blankestijn; Michael Böhm; Michel Burnier; Gilles Chatellier; Isabelle Durand Zaleski; Guido Grassi; Michael Joner; David E Kandzari; Ajay Kirtane; Sverre E Kjeldsen; Melvin D Lobo; Thomas F Lüscher; John William McEvoy; Gianfranco Parati; Patrick Rossignol; Luis Ruilope; Markus P Schlaich; Atif Shahzad; Faisal Sharif; Andrew S P Sharp; Horst Sievert; Massimo Volpe; Michael A Weber; Roland E Schmieder; Costas Tsioufis; William Wijns
EUROPEAN HEART JOURNAL - 21 Apr 2020
Don't Take It With a Pinch of Salt: How Sodium Increases Blood Pressure via the Gut Microbiota.
Hamdi A Jama; Francine Z Marques
CIRCULATION RESEARCH - 27 Mar 2020
Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy.
David Prior; Andre La Gerche
HEART, LUNG & CIRCULATION - 01 Apr 2020
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a group of cardiomyopathies associated with ventricular arrhythmias predominantly arising from the right ventricle, sudden cardiac death and right ventricular failure, caused largely due to inherited mutations in proteins of the desmosomal complex. Whilst long recognised as a cause of sudden cardiac death (SCD) during exercise, it has re...
Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
Darnel Prakoso; Miles J De Blasio; Mitchel Tate; Helen Kiriazis; Daniel G Donner; Hongwei Qian; David Nash; Minh Deo; Kate L Weeks; Laura J Parry; Paul Gregorevic; Julie R McMullen; Rebecca Helen Ritchie
AMERICAN JOURNAL OF PHYSIOLOGY. HEART AND CIRCULATORY PHYSIOLOGY - 01 Apr 2020
Diabetic cardiomyopathy is a distinct form of heart disease that represents a major cause of death and disability in diabetic patients, particularly, the more prevalent type 2 diabetes patient population. In the current study, we investigated whether administration of recombinant adeno-associated viral vectors carrying a constitutively active phosphoinositide 3-kinase (PI3K)(p110α) construct (r...
Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia.
Edward Abadir; Pablo A Silveira; Robin E Gasiorowski; Murari Ramesh; Adelina Romano; Ahmed H Mekkawy; Tsun-Ho Lo; Karieshma Kabani; Sarah Sutherland; Geoffrey A Pietersz; P Joy Ho; Christian E Bryant; Stephen R Larsen; Georgina J Clark
BLOOD ADVANCES - 14 Apr 2020
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) significantly reduces the rate of relapse in acute myeloid leukemia (AML) but comes at the cost of significant treatment-related mortality. Despite the reduction in relapse overall, it remains common, especially in high-risk groups. The outcomes for patients who relapse after transplant remains very poor. A large proportion of the m...
Potential Therapeutic Use of Neurosteroids for Hypertension.
Geoffrey A Head; Kristy L Jackson; Cindy Gueguen
FRONTIERS IN PHYSIOLOGY - 01 Jan 2019
The sympathetic nervous system (SNS) contribution to long-term setting of blood pressure (BP) and hence hypertension has been a continuing controversy over many decades. However, the contribution of increased sympathetic vasomotor tone to the heart, kidney, and blood vessels has been suggested as a major influence on the development of high BP which affects 30-40% of the population. This is rel...
Management of heart failure with preserved ejection fraction.
Emma Gard; Shane Nanayakkara; David Kaye; Harry Gibbs
AUSTRALIAN PRESCRIBER - 01 Feb 2020
SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection.
Lakshini Y Herat; Aaron L Magno; Caroline Rudnicka; Jana Hricova; Revathy Carnagarin; Natalie C Ward; Angelique Arcambal; Marcio G Kiuchi; Geoff A Head; Markus P Schlaich; Vance B Matthews
JACC. BASIC TO TRANSLATIONAL SCIENCE - 01 Feb 2020
Recent clinical trial data suggest a cardiorenal protective effect of sodium glucose cotransporter 2 (SGLT2) inhibition. We demonstrate that chemical denervation in neurogenic hypertensive Schlager (BPH/2J) mice reduced blood pressure, improved glucose homeostasis, and reduced renal SGLT2 protein expression. Inhibition of SGLT2 prevented weight gain, reduced blood pressure, significantly reduce...
HTLV-1c associated bronchiolitis in an Aboriginal man from central Australia.
Fabian Chiong; Hubertus Jersmann; Kim Wilson; Lloyd Einsiedel
IDCASES - 01 Jan 2020
We describe the first case of HTLV associated bronchiolitis to be associated with HTLV-1c subtype infection. An Aboriginal man with HTLV-1 infection was repeatedly admitted to Alice Springs Hospital, central Australia, with hypercapnic respiratory failure from the age of 28 years. High resolution CT chest findings were consistent with bronchiolitis and large numbers of lymphocytes were found in...
Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study.
Minna K Karjalainen; Michael V Holmes; Qin Wang; Olga Anufrieva; Mika Kähönen; Terho Lehtimäki; Aki S Havulinna; Kati Kristiansson; Veikko Salomaa; Markus Perola; Jorma S Viikari; Olli T Raitakari; Marjo-Riitta Järvelin; Mika Ala-Korpela; Johannes Kettunen
ATHEROSCLEROSIS - 01 Apr 2020
Apolipoprotein A-I (apoA-I) infusions represent a potential novel therapeutic approach for the prevention of coronary artery disease (CAD). Although circulating apoA-I concentrations inversely associate with risk of CAD, the evidence base of this representing a causal relationship is lacking. The aim was to assess the causal role of apoA-I using human genetics.We identified a variant (rs1222523...
[Lancet Commission on Hypertension Group position statement on the global improvement of accuracy standards for devices that measure blood pressurePosicionamento do Grupo da sobre a melhoria global dos padrões de acurácia para aparelhos que medem a pressão arterial].Lancet Commission on Hypertension
James E Sharman; Eoin O'Brien; Bruce Alpert; Aletta E Schutte; Christian Delles; Michael Hecht Olsen; Roland Asmar; Neil Atkins; Eduardo Barbosa; David Calhoun; Norm R C Campbell; John Chalmers; Ivor Benjamin; Garry Jennings; Stéphane Laurent; Pierre Boutouyrie; Patricio Lopez-Jaramillo; Richard J McManus; Anastasia S Mihailidou; Pedro Ordunez; Raj Padwal; Paolo Palatini; Gianfranco Parati; Neil Poulter; Michael K Rakotz; Clive Rosendorff; Francesca Saladini; Angelo Scuteri; Weimar Sebba Barroso; Myeong-Chan Cho; Ki-Chul Sung; Raymond R Townsend; Ji-Guang Wang; Tine Willum Hansen; Gregory Wozniak; George Stergiou;
REVISTA PANAMERICANA DE SALUD PUBLICA = PAN AMERICAN JOURNAL OF PUBLIC HEALTH - 01 Jan 2020
The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3 000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standa...
Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy.
Matthew Snelson; Sih Min Tan; Gavin C Higgins; Runa S J Lindblom; Melinda T Coughlan
AMERICAN JOURNAL OF PHYSIOLOGY. RENAL PHYSIOLOGY - 01 Mar 2020
Alterations in gut homeostasis may contribute to the progression of diabetic nephropathy. There has been recent attention on the renoprotective effects of metabolite-sensing receptors in chronic renal injury, including the G protein-coupled receptor (GPR)109a, which ligates the short-chain fatty acid butyrate. However, the role of GPR109a in the development of diabetic nephropathy, a milieu of ...
Weight Loss and Health Status 5 Years After Adjustable Gastric Banding in Adolescents.
Lindel C Dewberry; Anahita Jalivand; Resmi Gupta; Todd M Jenkins; Andrew Beamish; Thomas H Inge; Anita Courcoulas; Michael Helmrath; Mary L Brandt; Carroll M Harmon; Mike Chen; John B Dixon; Margaret Zeller; Marc P Michalsky
OBESITY SURGERY - 01 Jun 2020
This prospective cohort analysis describes changes in weight, cardiometabolic health, and weight-related quality of life (WRQOL) following adolescent LAGB.Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) collected demographic, anthropometric, micronutrient, cardiometabolic risk, and WRQOL data for 242 adolescents. Data through 5 years were analyzed for 14 participants who underwent...
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes.
Miles J De Blasio; Nguyen Huynh; Minh Deo; Leslie E Dubrana; Jesse Walsh; Andrew Willis; Darnel Prakoso; Helen Kiriazis; Daniel G Donner; John C Chatham; Rebecca H Ritchie
FRONTIERS IN PHYSIOLOGY - 01 Jan 2020
The incidence of diabetes and its association with increased cardiovascular disease risk represents a major health issue worldwide. Diabetes-induced hyperglycemia is implicated as a central driver of responses in the diabetic heart such as cardiomyocyte hypertrophy, fibrosis, and oxidative stress, termed diabetic cardiomyopathy. The onset of these responses in the setting of diabetes has not be...
Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome.
Matthias Arnold; Kwangsik Nho; Alexandra Kueider-Paisley; Tyler Massaro; Kevin Huynh; Barbara Brauner; Siamak MahmoudianDehkordi; Gregory Louie; M Arthur Moseley; J Will Thompson; Lisa St John-Williams; Jessica D Tenenbaum; Colette Blach; Rui Chang; Roberta D Brinton; Rebecca Baillie; Xianlin Han; John Q Trojanowski; Leslie M Shaw; Ralph Martins; Michael W Weiner; Eugenia Trushina; Jon B Toledo; Peter J Meikle; David A Bennett; Jan Krumsiek; P Murali Doraiswamy; Andrew J Saykin; Rima Kaddurah-Daouk; Gabi Kastenmüller
NATURE COMMUNICATIONS - 02 Mar 2020
Late-onset Alzheimer's disease (AD) can, in part, be considered a metabolic disease. Besides age, female sex and APOE ε4 genotype represent strong risk factors for AD that also give rise to large metabolic differences. We systematically investigated group-specific metabolic alterations by conducting stratified association analyses of 139 serum metabolites in 1,517 individuals from the AD Neuroi...
Targeting Treatment Refractory NET by EZH2 Inhibition in Postural Tachycardia Syndrome.
Harikrishnan Kaipananickal; Abdul Waheed Khan; Susan J Corcoran; Murray D Esler; Jun Okabe; Assam El-Osta
CIRCULATION RESEARCH - 03 Mar 2020
Show more...